Filing Flows › CorMedix (CRMD) › Net income
CorMedix (CRMD) net income by quarter
CorMedix's net income was $26.0M in Q2 2026 (second quarter 2026), -33% from Q1 2026. Over the last 7 quarters it ranged from $13.5M (Q4 2024) to $109M (Q3 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $26.0M | -33% | +31% |
| Q1 2026 | $38.6M | +175% | +87% |
| Q4 2025 | $14.0M | -87% | +4% |
| Q3 2025 | $109M | +448% | — |
| Q2 2025 | $19.8M | -4% | — |
| Q1 2025 | $20.6M | +53% | — |
| Q4 2024 | $13.5M | — | — |
Q2 2026 at a glance
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is CorMedix's net income?
CorMedix's net income was $26.0M in Q2 2026 (second quarter 2026), -33% from Q1 2026.
How has CorMedix's net income changed?
Over the last 7 quarters it ranged from $13.5M (Q4 2024) to $109M (Q3 2025).